ABOS Price Chart
Loading chart...
50 DMA150 DMA200 DMA
ABOSAcumen Pharmaceuticals, Inc.
$1.86
Financials
NEUTRAL
Investment Thesis
ABOS is neither a clear buy nor avoid. RS 75/99, moderate earnings. keep it on your radar.
Mixed signals = No edge currently
Key Takeaways
- Earnings moderate
- RS 75 - needs improvement
- No base pattern
- Wait & watch
Earnings Momentum
Earnings Declining
Price Structure
Partial AlignmentPrice
$1.86
→
50 DMA
$1.91
✓→
100 DMA
$1.81
✓→
150 DMA
$1.65
✓→
200 DMA
$1.50
Alignment Score: 3/4
Why Not BUY Yet?
RS Rating
75 (Top 25%)→>80 (Top 20%)
EPS Growth
12%→>25% (Strong) or 40%+ (Elite)
Pattern
No base forming→VCP or constructive base
Breakout Status
-4.1% from entry ($1.94)→Breakout confirmation (hold above entry)
What Would Change Our Mind?
To turn bullish on ABOS, we need:
- RS Rating: >80 (Top 20%)(currently 75 (Top 25%))
- EPS Growth: >25% (Strong) or 40%+ (Elite)(currently 12%)
- Pattern: VCP or constructive base(currently No base forming)
- Breakout Status: Breakout confirmation (hold above entry)(currently -4.1% from entry ($1.94))
- Breakout Recovery: Price recovers above $1.94(currently -4.1% below entry)
Twin Engines Dashboard
Technical Health
RS Rating
75/99
Top 25% (Need 80+)
Trend
Uptrend
Above 200 DMA
RSI (14)
41
NEUTRAL
VCP Setup
COOL
Score: 1/9
Volume
128K
-29% vs avg
From Entry
-4.1%
$1.94
Fundamental Horsepower
EPS Qtr YoY
+12%
Accelerating
EPS 3Y CAGR
N/A
Annual Earnings
Revenue Qtr
N/A
NO DATA
F-Score
1/9
Piotroski Quality
ROE
-46%
Return on Equity
EPS Rank
21/99
Percentile
Trade Plan
StrugglingBreakout Date2025-10-06102 days ago
Entry Was$1.94Breakout price
Loss Since-4%From entry
Wait For$1.94Reclaim entry or new base
If/Then Playbook
IF: RS Rating improves to >80
THEN: Re-evaluate for potential
IF: EPS growth accelerates next quarter
THEN: Check for developing setup
IF: VCP pattern begins forming
THEN: Add to watchlist if RS also improving
IF: Price breaks below 200 DMA
THEN: Remove from radar
Key Price Levels
Resistance
- 50 DMA$1.91+2.8%
- 20 DMA$1.99+7.2%
- 52W High$2.46+32.3%
Current$1.86
Support
- 200 DMA$1.50-19.2%
- 52W Low$0.86-54.0%
More ABOS Analysis
Frequently Asked Questions
Is ABOS stock a buy now?
ABOS is neither a clear buy nor avoid. RS 75/99, moderate earnings. keep it on your radar.
What is the buy point for ABOS?
ABOS broke out at $1.94 3 month(s) ago but is now -4% below entry. Wait for new base pattern.
What is ABOS's RS Rating?
ABOS has an RS Rating of 75/99, meaning it's in the Top 25% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.
Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.